Further studies revealed that CASC19 contributes to NSCLC progression by regulating the miR-301b-3p/LDLR interaction, leading to increased LDLR expression and enhanced tumor cell growth and metastasis.146. Here, LDLR is linked to non-small cell lung carcinoma.